Does Pulmonary Hypertension Cause Left Ventricular Hypertrophy?
Pulmonary hypertension does not typically cause left ventricular hypertrophy (LVH); instead, LVH in the presence of pulmonary hypertension usually indicates underlying left heart disease that is actually causing the pulmonary hypertension, not the reverse. This is a critical diagnostic distinction that fundamentally changes patient management.
The Diagnostic Framework
When you encounter a patient with both PH and LVH, you must think backwards from the typical assumption. The 2009 ESC/ERS guidelines explicitly list LVH as an echocardiographic sign that favors the diagnosis of left ventricular diastolic dysfunction as the cause of pulmonary hypertension, not as a consequence of it 1. This appears in their diagnostic algorithm for distinguishing PH due to left heart disease from other forms of PH.
Key Clinical Features Suggesting LVH is the Cause, Not the Effect:
When evaluating patients with PH and LVH, look for these specific findings that indicate left heart disease is driving the PH 2:
- Age >65 years
- Systemic hypertension (elevated systolic BP, elevated pulse pressure)
- Metabolic syndrome features (obesity, diabetes)
- Coronary artery disease
- Atrial fibrillation
- Left atrial enlargement (>4.2 cm)
- Concentric LV remodeling (relative wall thickness >0.45)
The Exception: Neonatal and Pediatric Populations
There is one important exception where PH can contribute to LVH. In neonates with persistent pulmonary hypertension and chronic lung disease of infancy (CLDI), LVH can develop through distinct pathophysiologic mechanisms 3:
Mechanisms in Neonates:
- Chronic hypoxemia, hypercarbia, and acidosis increase cardiac output and stimulate the renin-angiotensin system, elevating LV afterload
- More negative intrathoracic pressure during inspiration increases LV afterload
- Myocardial scarring from metabolic stress
- Systemic hypertension (occurs in ~43% of CLDI patients) further contributes to LVH
However, even in this population, systemic hypertension is often the intermediate mechanism, not direct effects of pulmonary hypertension on the left ventricle 3.
Clinical Pitfalls to Avoid
Do not assume PH causes LVH in adult patients. This is a common diagnostic error. When you see both findings together:
- First, aggressively evaluate for left heart disease as the primary problem causing secondary PH
- Look for the clinical features listed above that indicate PH-LHD
- Consider that the patient may have Group 2 PH (PH due to left heart disease), which is the most common form of PH globally 4
- Remember that optimal treatment of the underlying left heart disease is the Class I recommendation for PH-LHD, not PAH-specific therapies 1
Diagnostic Approach
When encountering PH with LVH on echocardiography:
- Assess Doppler indices for elevated LV filling pressures (increased E/e' ratio, abnormal mitral flow patterns) 2
- Evaluate for structural left heart abnormalities (valvular disease, LA enlargement, concentric remodeling)
- Consider right heart catheterization to measure pulmonary wedge pressure (PWP) - if PWP >15 mmHg, this confirms PH-LHD 2
- Screen for systemic hypertension, which may be the unifying diagnosis explaining both findings
The 2015 ESC/ERS guidelines emphasize that PAH-specific drug therapy is not recommended (Class III) in patients with PH due to left heart disease 2. Misdiagnosing the direction of causality can lead to inappropriate and potentially harmful treatment.
Bottom Line
In adults, when you see PH and LVH together, the LVH is almost always the cause of the PH, not the consequence. Treat the left heart disease aggressively. Only in specific neonatal/pediatric populations with severe chronic lung disease does PH contribute to LVH development through indirect mechanisms involving systemic hypertension and metabolic stress.